Hu H - Search Results

1

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer.

Hu H, Tan S, Xie M, Guo P, Yu Q, Xiao J, Zhao K, Liao Q, Wang Y. Hu H, et al. Front Pharmacol. 2023 Aug 29;14:1167959. doi: 10.3389/fphar.2023.1167959. eCollection 2023. Front Pharmacol. 2023. PMID: 37705536 Free PMC article.

2

Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway.

Hu H, Liu Y, Tan S, Xie XX, He J, Luo F, Wang L. Hu H, et al. Cancer Manag Res. 2020 May 19;12:3579-3587. doi: 10.2147/CMAR.S243660. eCollection 2020. Cancer Manag Res. 2020. PMID: 32547195 Free PMC article.

3

The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment.

Hu H, Chen Y, Tan S, Wu S, Huang Y, Fu S, Luo F, He J. Hu H, et al. Front Immunol. 2022 Feb 23;13:802846. doi: 10.3389/fimmu.2022.802846. eCollection 2022. Front Immunol. 2022. PMID: 35281003 Free PMC article. Review.

4

Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer.

Fu S, Li L, Li X, Wu Q, Wang X, Huang Y, Hu H, Cao D. Fu S, et al. Among authors: hu h. Front Pharmacol. 2022 Aug 10;13:888106. doi: 10.3389/fphar.2022.888106. eCollection 2022. Front Pharmacol. 2022. PMID: 36034835 Free PMC article.

5

The role of neutrophil extracellular traps in cancer progression, metastasis and therapy.

Chen Y, Hu H, Tan S, Dong Q, Fan X, Wang Y, Zhang H, He J. Chen Y, et al. Among authors: hu h. Exp Hematol Oncol. 2022 Nov 16;11(1):99. doi: 10.1186/s40164-022-00345-3. Exp Hematol Oncol. 2022. PMID: 36384979 Free PMC article. Review.

6

Case report: Highly differentiated endometrial adenocarcinoma that collided with uterine cervical carcinosarcoma.

Fan X, Hu H, Liu Y, Tan S, Xie M, Zhang F. Fan X, et al. Among authors: hu h. Front Med (Lausanne). 2023 Jan 26;10:1044196. doi: 10.3389/fmed.2023.1044196. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36778737 Free PMC article.

7

Interleukin-9 promotes tumorigenesis through augmenting angiogenesis in non-small cell lung cancer.

He J, Wang L, Zhang C, Shen W, Zhang Y, Liu T, Hu H, Xie X, Luo F. He J, et al. Among authors: hu h. Int Immunopharmacol. 2019 Oct;75:105766. doi: 10.1016/j.intimp.2019.105766. Epub 2019 Jul 25. Int Immunopharmacol. 2019. PMID: 31352324

8

Interleukin-36α suppresses growth of non-small cell lung cancer in vitro by reducing angiogenesis.

Xie X, Hu H, He J, Liu Y, Guo F, Luo F, Jiang M, Wang L. Xie X, et al. Among authors: hu h. FEBS Open Bio. 2021 May;11(5):1353-1363. doi: 10.1002/2211-5463.13141. Epub 2021 May 2. FEBS Open Bio. 2021. PMID: 33713575 Free PMC article.

9

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma.

Chen Y, Hu H, Yuan X, Fan X, Zhang C. Chen Y, et al. Among authors: hu h. Front Immunol. 2022 Jun 10;13:896752. doi: 10.3389/fimmu.2022.896752. eCollection 2022. Front Immunol. 2022. PMID: 35757756 Free PMC article. Review.

10

Co-existence of well-differentiated fetal adenocarcinoma of the lung with tuberculosis in a young female: A rare case report.

Guo F, Wang J, Hu H, Xie X, Liu K, Luo F. Guo F, et al. Among authors: hu h. Medicine (Baltimore). 2019 Dec;98(49):e18282. doi: 10.1097/MD.0000000000018282. Medicine (Baltimore). 2019. PMID: 31804370 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,293 results

Search Page

Filters